I came across this interesting chart on the long-term real returns of US stocks. According to this chart, currently we are in the aftermath phase of a secular bull market. Click to enlarge Source: Global Investor 1.14 – Europe, August 2014, Credit Sussie Over the very long long-term equities tend to go higher…..
European stocks have been laggards this years relative to the decent performance of U.S. stocks. However moving forward, European stocks have better growth potential compared to their American peers for a variety of reasons two of which are discussed in this post. 1. Currently U.S. stocks are expensive while European equities are relatively cheap based on …
Continue reading ‘Two Reasons On Why European Stocks Have Room To Grow’ »
The total assets of the U.S. Federal Reserve stood at over $4.0 Trillion at in December 2013. To be more exact, it reached a record high of $4,008,062,000,000. Click to enlarge Source: Fed’s assets top $4 trillion, CNN, Dec 19, 2013 It is not just the balance sheets of the Fed and the European Central Bank …
Continue reading ‘A Comparison Of The Assets Of Central Banks of Major Economies’ »
The Australian equity market provides one of the best opportunities for investors hunting for foreign dividend stocks. As a developed economy the country has positive factors that are common in other developed countries such as those in Europe, the US, etc. For example, political risk is practically zero. Though the Australian economy is a resource-based economy …
Continue reading ‘Six Reasons To Invest In Australian Dividend Stocks’ »
One of the important metrics to evaluate pharmaceutical companies is the total number of drugs that are in the pipeline. Companies not only depend on new drugs for future revenue growth but also look to new drugs in development to replace revenues lost when patents expire on their existing drugs. The Top 10 pharmaceutical companies based …
Continue reading ‘The Top 10 Pharmaceutical Companies By Size Of Pipeline’ »